HBV testing and diagnosis of HBV-related liver disease in low-income and middle-income
countries differs substantially from that in developed countries in terms of access to …

Blood transfusions are vital components of modern medical treatment to which there is no
viable alternative despite efforts to create artificial blood. Each year thousands of lives are …

Background: Assessing trends in the rate of transfusion-transmissible infections (TTIs) in
blood donors is critical to the monitoring of the blood supply safety and the donor screening …

Background Most major Chinese blood centres look for hepatitis B surface antigen (HBsAg)
and perform nucleic acid testing to screen blood for hepatitis B virus infection. The search for …

Abstract Background Hepatitis B virus (HBV) surface antigen (HBsAg) screening in blood
banks reduced the risk of HBV transmission through transfusion. However, the detection of …

BACKGROUND Occult hepatitis B virus (HBV) infection (OBI) in blood donors was
investigated in the Baoji area of North China, and OBI‐related viral mutations in donors were …

Although not mandatory in France, HBV-NAT has been implemented in overseas territories
in 2005, in Army services in 2006 and progressively in mainland France in 2010 when the …

Background The present study determined the HBV antigen, antibody, and DNA status in
blood donations deemed to be HBV positive. Individuals with an occult HBV infection (OBI) …

Occult hepatitis B (OHB) is characterized by the presence of HBV‐DNA in the absence of
HBsAg in the serum of patients. Hemodialysis patients are at high risk for hepatitis B virus …

BACKGROUND Many studies have identified mutations in the hepatitis B surface antigen
(HBsAg) as important factors limiting the ability of commercial serological assays to detect …